Denemek ALTIN - Özgür
Deficiencies Are Mainly Due To Lack Of Knowledge On Nutrition
Express Pharma
|August 16-31, 2019
Rohit Shelatkar, VP, Vitabiotics discusses the dismal state of health and healthcare among Indian women, steps that can be taken to improve this situation and the importance of nutritional supplements in a woman's regular diet, in a one-on-one chat with Tarannum Rana
-
Meyer has had a good growth trajectory over the years. Can you share any interesting anecdote on the journey so far?
Meyer Organics, founded in 1982, is one of the fastest growing healthcare companies in India. It is the sister company of Vitabiotics, UK’s number one vitamin company in London, founded in 1971. Vitabiotics has a unique portfolio of products at the forefront of scientific developments in key sectors, including nutrition and women’s health, based on clinical research. For close to five decades, Vitabiotics and Meyer have dedicatedly provided the market with innovative and effective products based on sophisticated nutrient technology. We partner with various leading universities around the world for nutritional research and also actively work with many worldwide charities.
Vitabiotics is also the only vitamin company in the world that has won the prestigious Queen’s Award four times, two of which were for Innovation in Vitamin Research for our successful clinical research for Pregnacare and also Perfectil. This product has captured almost 90 per cent of the UK’s market share for pregnancy related products.
Vitabiotics and Meyer are also pioneers of nutrition research as we have always brought new concepts to the market. For example, Meyer was the first company to introduce Magnesium alongside vitamin D3 for calcium absorption, with our launch of the Calcimax range. We were the first company to introduce the right level of folic acid for pregnancy, 400ug, much before the Department of Health of the UK, made the official recommendation for pregnant women. Over the course of our 48-year history, the development of new products at Vitabiotics and Meyer has been fuelled by a fundamental desire to deliver natural healthcare solutions that are safe, effective and relevant to our customers’ needs.
Bu hikaye Express Pharma dergisinin August 16-31, 2019 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Express Pharma'den DAHA FAZLA HİKAYE
Express Pharma
Speed and flexibility play a critical role in how we compete with larger global players
Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma
6 mins
January 2026
Express Pharma
Vizag rising: Shaping India's pharma future
At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth
9 mins
January 2026
Express Pharma
Future of pharma: Trends, challenges & AI
Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies
2 mins
January 2026
Express Pharma
Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments
When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.
1 mins
January 2026
Express Pharma
Can Indian biosimilars and generics restate accessibility in global underserved markets?
Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare
3 mins
January 2026
Express Pharma
The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers
As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.
6 mins
January 2026
Express Pharma
Results win customers. Leadership discipline keeps them
Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.
3 mins
January 2026
Express Pharma
INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF
India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge
8 mins
January 2026
Express Pharma
PRUV® -The original Sodium Stearyl Fumarate
JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago
5 mins
January 2026
Express Pharma
Odisha's pharma pitch
The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury
5 mins
January 2026
Translate
Change font size
